116 related articles for article (PubMed ID: 17267790)
1. A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapy.
Marcus SM; Gorman J; Shear MK; Lewin D; Martinez J; Ray S; Goetz R; Mosovich S; Gorman L; Barlow D; Woods S
Am J Psychiatry; 2007 Feb; 164(2):273-5. PubMed ID: 17267790
[TBL] [Abstract][Full Text] [Related]
2. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.
Barlow DH; Gorman JM; Shear MK; Woods SW
JAMA; 2000 May; 283(19):2529-36. PubMed ID: 10815116
[TBL] [Abstract][Full Text] [Related]
3. The side effects burden of extended imipramine treatment of panic disorder.
Mavissakalian MR; Perel JM
J Clin Psychopharmacol; 2000 Oct; 20(5):547-55. PubMed ID: 11001240
[TBL] [Abstract][Full Text] [Related]
4. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
[TBL] [Abstract][Full Text] [Related]
5. Preliminary evidence for cognitive mediation during cognitive-behavioral therapy of panic disorder.
Hofmann SG; Meuret AE; Rosenfield D; Suvak MK; Barlow DH; Gorman JM; Shear MK; Woods SW
J Consult Clin Psychol; 2007 Jun; 75(3):374-9. PubMed ID: 17563154
[TBL] [Abstract][Full Text] [Related]
6. Panic disorder: long-term pharmacotherapy and discontinuation.
Rickels K; Schweizer E
J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
[TBL] [Abstract][Full Text] [Related]
7. Imipramine vs. sertraline in panic disorder: 24-week treatment completers.
Mavissakalian MR
Ann Clin Psychiatry; 2003; 15(3-4):171-80. PubMed ID: 14971862
[TBL] [Abstract][Full Text] [Related]
8. Cost-efficacy of individual and combined treatments for panic disorder.
McHugh RK; Otto MW; Barlow DH; Gorman JM; Shear MK; Woods SW
J Clin Psychiatry; 2007 Jul; 68(7):1038-44. PubMed ID: 17685740
[TBL] [Abstract][Full Text] [Related]
9. Physical, mental, and social catastrophic cognitions as prognostic factors in cognitive-behavioral and pharmacological treatments for panic disorder.
Hicks TV; Leitenberg H; Barlow DH; Gorman JM; Shear MK; Woods SW
J Consult Clin Psychol; 2005 Jun; 73(3):506-14. PubMed ID: 15982148
[TBL] [Abstract][Full Text] [Related]
10. Fluctuation of symptoms and social functioning in panic disorder with or without concomitant depression. A 5-year prospective follow-up.
Albus M; Scheibe G; Scherer J
Psychopathology; 1995; 28(5):229-34. PubMed ID: 8559945
[TBL] [Abstract][Full Text] [Related]
11. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
Cohn JB; Wilcox C
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.
Nair NP; Bakish D; Saxena B; Amin M; Schwartz G; West TE
Anxiety; 1996; 2(4):192-8. PubMed ID: 9160622
[TBL] [Abstract][Full Text] [Related]
13. Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
Mavissakalian MR; Perel JM
Arch Gen Psychiatry; 1999 Sep; 56(9):821-7. PubMed ID: 12884888
[TBL] [Abstract][Full Text] [Related]
14. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Rickels K; Schweizer E; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
[TBL] [Abstract][Full Text] [Related]
15. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
Modigh K; Westberg P; Eriksson E
J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
[TBL] [Abstract][Full Text] [Related]
16. Follow-up study of patients with panic disorder.
Judd FK; Burrows GD; Norman TR
Arch Gen Psychiatry; 1991 Sep; 48(9):860-2. PubMed ID: 1929779
[No Abstract] [Full Text] [Related]
17. Pretreatment attrition in a comparative treatment outcome study on panic disorder.
Hofmann SG; Barlow DH; Papp LA; Detweiler MF; Ray SE; Shear MK; Woods SW; Gorman JM
Am J Psychiatry; 1998 Jan; 155(1):43-7. PubMed ID: 9433337
[TBL] [Abstract][Full Text] [Related]
18. Cognitive behavior therapy for treatment-refractory panic disorder.
Pollack MH; Otto MW; Kaspi SP; Hammerness PG; Rosenbaum JF
J Clin Psychiatry; 1994 May; 55(5):200-5. PubMed ID: 8071270
[TBL] [Abstract][Full Text] [Related]
19. Emotion-focused psychotherapy for patients with panic disorder.
Shear MK; Houck P; Greeno C; Masters S
Am J Psychiatry; 2001 Dec; 158(12):1993-8. PubMed ID: 11729015
[TBL] [Abstract][Full Text] [Related]
20. Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study.
Noyes R; Garvey MJ; Cook BL; Samuelson L
J Clin Psychiatry; 1989 May; 50(5):163-9. PubMed ID: 2715139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
